Skip to content

Air Filtration for COPD in VA Population of Veterans

Air Filtration to Improve Indoor Air Quality (IAQ) and Chronic Obstructive Pulmonary Disease (COPD) Outcomes in a High-risk Urban Population of U.S. Military Veterans

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05913765
Enrollment
80
Registered
2023-06-22
Start date
2023-01-11
Completion date
2025-12-31
Last updated
2024-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Brief summary

The goal of this study is to investigate the effectiveness of stand-alone air filtration for improving indoor air quality (IAQ) and chronic obstructive pulmonary disease (COPD) outcomes in a high-risk urban cohort of 80 U.S. military veterans with COPD. Secondary goals of the study are to (1) investigate housing-related factors that may contribute to COPD exacerbation, (2) investigate the utility of using low-cost sensors for indoor air pollution epidemiology studies and for providing actionable or useful information on the quality of their indoor air to patients and their physicians, and (3) evaluate the costs and benefits of using stand-alone air filtration to improve IAQ and COPD outcomes.

Detailed description

The study will utilize a randomized, single-blind, placebo-controlled case-control design in which stand-alone portable air cleaners will be introduced to the study population over a period of approximately 1 year. One-half of the study population (40 participants) will receive a normally functioning filtration unit (i.e., an air cleaner with HEPA filter installed) and one-half of the study population (40 participants) will receive a placebo filtration unit (i.e., an air cleaner with the primary filter removed). The participants will be blinded; they will not know the status of the filter. Stand-alone portable air cleaning units containing HEPA filters and high clean air delivery rates (CADRs) sufficiently sized for the spaces they will serve will be used. The study will also involve housing condition assessments conducted in each home to characterize housing-related factors that may contribute to COPD exacerbation at baseline, as well as measurements of indoor and outdoor air quality and environmental conditions, and records of clinical outcomes (e.g., COPD exacerbations, emergency room visits, 6-minute walk distance, oxygen saturation, etc. accessed through the subject's VA medical record) throughout the study duration. The validated and extensively used St. George's Respiratory Questionnaire (SGRQ-C) and Veterans RAND 36-Item Health Survey (VR-36) will be used to determine health-related quality of life (HR-QoL) of participants by the JBVAMC Study Personnel. Clinical outcomes will also be used to assess costs of care with and without filtration interventions in this population. Low-cost air quality sensors will be used to monitor IAQ for the duration of the study). The study will also evaluate the upfront costs and operational and maintenance costs of the air cleaners over the course of the intervention periods and will compare them to the expected impacts on costs of care both with and without filtration interventions in this population.

Interventions

Austin Air Healthmate air cleaner with or without standard filter

Sponsors

Jesse Brown VA Medical Center
CollaboratorFED
US Department of Housing and Urban Development
CollaboratorFED
Elevate
CollaboratorUNKNOWN
Illinois Institute of Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Randomized, single-blind, placebo-controlled case-control design

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age: 18 - 90+ years. 2. English speaking and writing. 3. Able to provide consent. 4. Resident of Chicago metropolitan area. 5. Veteran receiving health care at JBVAMC with a documented diagnosis of COPD. 6. Stable housing for at least 6 months prior to screening. 7. Able to communicate regularly by telephone.

Exclusion criteria

1. Home palliative care. 2. Life expectancy \<6 months. 3. Hazardous conditions and/or safety concerns in or around the veteran's household 4. Screened patients that already have an air cleaner and alike in his/her current residence 5. Concomitant operation of a non-study air cleaner and alike by a participant in his/her current residence at any time during the course of the trial constitutes protocol violation leading to disqualification of said participant from the study.

Design outcomes

Primary

MeasureTime frameDescription
COPD exacerbationsThrough study completion, an average of 1 yearPhysician diagnosed exacerbation of acute COPD

Secondary

MeasureTime frameDescription
Urgent care visitsThrough study completion, an average of 1 yearNumber of urgent care visits
Unscheduled clinic visitsThrough study completion, an average of 1 yearNumber of unscheduled clinic visits
6MWDAt the end of study completion, an average of 1 year6-minute walk distance
ED visitsThrough study completion, an average of 1 yearNumber of emergency room visits
Health related quality of lifeAt the end of study completion, an average of 1 yearVeterans Rand 36 Item Healthy Survey (VR 36)
St. George'sAt the end of study completion, an average of 1 yearSt. George's Respiratory Questionnaire (SGRQ) score
O2 satAt the end of study completion, an average of 1 yearTranscutaneous oxygen saturation at rest and during 6MWD

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026